Zhejiang University Researcher Releases New Study Findings on Gene Therapy (Recent Advancements in Biomaterials for Chimeric Antigen Receptor T Cell Immunotherapy).

A recent study conducted by researchers at Zhejiang University in Hangzhou, China, explores the use of gene therapy in cellular immunotherapy for cancer treatment. The study focuses on chimeric antigen receptor T cell (CAR-T) therapy and discusses the potential of biomaterials in enhancing the efficacy of this treatment. The researchers also address the use of animal models for evaluating the effectiveness of these therapies. This research provides valuable insights into the advancements in biomaterials for chimeric antigen receptor T cell immunotherapy. [Extracted from the article]

Copyright of Cancer Gene Therapy Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)